I
IADT (International Association of Dental Traumatology),
622
IANC (bifid inferior alveolar nerve canal),
435f
IASP (International Association for the Study of Pain),
60
iatrogenic root fractures,
25–26
ibuprofen compared to acetaminophen,
686f
ID (interglobular dentin),
460,
460f
IEE (inner enamel epithelium),
454f,
456f
imaging instruments/systems
See also cone-beam volumetric tomography (CBVT) See also radiography See also technology/digital technology See also ultrasonic equipment
digital,
108f,
966–967
complementary metal oxide semiconductor (CMOS) direct sensor,
985f
computer interface for,
992
DICOM compliant units,
994f
effective doses from x-ray procedures,
994t
patient education systems,
989
storage and compression of images,
991
visible light (VL) imaging,
982b
workflow improvement,
989
Kodak 9000 3D extraoral imaging system,
994f
immune response
bacterial toxins in activation of,
531
implants,
267f,
760f
endodontic therapy versus,
80
into inferior alveolar nerve canal,
442f
neuropathic complications of mandibular,
59
survival rate of,
80,
723
incisive nerve block at mental foramen,
699
incremental filling technique,
780
indirect composite restorations,
781
indirect foundation restorations,
785–786
indirect pulp therapy (IPT), in primary teeth,
821–822
infections
See also microorganisms
after luxation injuries,
641f
biofilm and community-based microbial pathogenesis in,
565–568,
566f
control guidelines,
88–90
furcal and periapical,
833
high-risk patients,
76–77
host-parasite interactions and,
531–532
influence on outcomes of,
82
of maxillary and mandibular molars,
12–13
mechanisms of pathogenicity,
562–565
as medical emergencies,
45
microbial pathogenicity and virulence mechanisms,
563f–564f
nonvital infected teeth,
46f
primary
nonbacterial microorganisms,
579–580
prophylactic treatment for,
685
pulpal, and restorations/restorative procedures,
28f
secondary/persistent,
580–584
bacteria at the root canal-filling stage,
581–582
infective endocarditis,
445
infiltration injections,
699
solutions for
articaine/epinephrine,
703
bupivacaine/epinephrine,
703
mepivacaine/prilocaine,
703
prilocaine/epinephrine,
703
inflammation/inflammatory response,
52,
672–673,
683
acute immunoinflammatory response,
540
circulation in inflamed pulp,
488–489
corticosteroid affects on,
683
hallmarks of pain perception due to,
673–674
inflamed interstitium,
472
inflammatory mediators,
482
influence on pulp of periodontal,
657
innate immunoinflammatory response,
539t
interproximal inflammatory tissue,
635
neuronal changes with,
673
reduction of chemical mediators of,
676
sensitization of nerve fibers with,
54–55
inflammatory phase of healing,
723–725
informed consent,
95
avoiding patient claims,
418
different schools of thought on,
417–418
endodontic informed consent,
418
patient preparation/education,
95
for periradicular surgery,
734
video-informed consent,
418
infraorbital nerve blocks,
704
infraorbital (canine) space infections,
9,
9f,
593–594
inhibitory action (- sign),
675f
injection sites/techniques for local anesthesia,
700f,
705f
accuracy of injections,
701
incisive nerve block at mental foramen,
699
inferior alveolar nerve blocks,
699–700
infiltration injections of,
699
mandibular first molar infiltration injections,
699–700
maxillary,
704–705
anterior middle superior alveolar (AMSA) nerve block,
705
infraorbital nerve block,
704
palatal-anterior superior alveolar (P-ASA) nerve block,
704
posterior superior alveolar (PSA) nerve block,
704
second division nerve block,
704
Vazirani-Akinosi technique,
699
inner enamel epithelium (IEE),
454f,
456f
innervators of inflamed tissue,
673
Instrument Removal System kit,
933–934
instruments,
127f,
153–157,
325f,
891fSee also specific instruments by name, e.g. Greater Taper
canal identification and enlargement,
153f
chairside disinfection of,
132
coated root-end preparation,
751–752
dental operating microscopes (DOMs),
145f
instrument management system (IMS),
126f
manufacturing process of most,
295
measuring of root canal space,
230–243
negotiating the canal,
173f
orifice enlargement,
323f
penetration instruments,
173f
recommended motion for,
310
removal of dentin/locating calcified canals,
173f
for routine endodontic care,
125b
stands/holders for instruments,
127f
using combination of,
330b
insurance
carrier warnings about articaine,
698–699
Health Insurance Portability and Accountability Act (HIPAA),
91,
405–406
intensity of symptoms,
6,
64
interactions of irrigants,
336f
interglobular dentin (ID),
460,
460f
intermediate restorative material (IRM),
753
internal resorption,
623f
internal root resorption,
644,
646
International Association for the Study of Pain (IASP),
60
International Association of Dental Traumatology (IADT),
622
International Headache Society,
56–57
interpersonal skills,
1025
interradicular pathosis,
285f
interstitium, inflamed,
472
interviewing for dental history,
6,
957–958
intracanal medication,
253–255
administration of analgesics, corticosteroids,
683
phenolic preparations,
253
triple-antibiotic paste,
255
intracoronal attachments,
872f
intracranial structures,
61
intraligamentary anesthesia,
702,
705–707
amount of solution delivered,
706
anesthetic solutions,
706
duration of anesthesia,
706
ligamental syringes for,
706
selective anesthesia with,
706
IntraLight ultraviolet disinfection,
259–260
intraoral examinations,
10–15
intraoral radiographs,
20–21
intraosseous route for local anesthesia,
707–711,
708f
plasma levels of lidocaine after,
711
postoperative problems,
711
intrapulpal route for local anesthesia,
512,
711–712
intratubular nerve endings,
477
in vivo/in vitro cleaning/shaping,
292f
IPT (indirect pulp therapy), in primary teeth,
821–822
irradiation methods, laser,
272–275
irreversible pulpitis,
16f,
36–37,
40–41
antibiotics, for emergent,
41
medical conditions influencing,
75f
pain management strategies for,
714
pretreatment of tooth,
320f
single-visit treatment for,
42
straight-line access example,
324f
irrigation/irrigants
See also disinfection/disinfectants
choosing the ideal irrigant,
253
into dentinal tubules,
315f
effectiveness studies on,
250
efficacy in deactivating microorganisms of,
313t
heating syringes for,
337f
interactions between,
250
interactions with dentin of,
777
iodine potassium iodide (IKI),
253,
314
modes and devices,
331–334
negative and positive pressure,
334
ultrasonically activated,
334
movement/distribution of,
317f
needle sizes and manufacturers,
246t,
335f
new techniques and devices,
255–260
noninstrumentation technique,
339
oxidative potential water,
316
properties of ideal,
336b
in regeneration of smear layer,
609
replacement of fluid,
258f
for treatment of apical periodontitis,
589–590
ultrasonically activated,
339
isolated bone loss,
29–30
ISO-normed instruments,
290